INGN
InogenANasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
INGN vs peer average
70/100
INGN vs. peer average (A vs. B)
Grade spread
A 5 · B 2 · C 1 · D 2 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
VMD is the first available peer comparator.
Viemed is identified in Inogen’s 2025 annual report as a leading respiratory therapy provider; it is not a pure device comp, but it is a useful read-through for home-respiratory demand and reimbursement sensitivity.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
INGN
Inogen
VMD
Viemed Healthcare
Grade
A
A
Momentum
7
5
Value
37
70
Sentiment
99
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs VMD
INGN / VMD
Grade Position
Above peers
INGN vs. peer average (A vs. B)
70/100
Momentum
7
INGNValue
37
VMDSentiment
99
VMDRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs INGN
VMD is the first peer returned for this comparison set.